Lomustine 40mg
Product Overview | |
Generic Name | Lomustine 40mg |
Brand Name(s) | Gleostine, CCNU, CeeNu, Ceenu, Lomuwin, Lomoother, Belustine |
Form | Oral hard gelatin capsules /100 Cap Package |
Strength | 40 mg |
Therapeutic Class | Alkylating agent (nitrosourea) |
ATC Code | L01AD02 |
Manufacturing & Regulatory | |
Manufacturer | GSK, Chandra Bhagat, Samarth Life Sciences, TherDose, Intas, Saintroy, Ocean Pharma, Lexicare, PBP, Blue Earth, |
Country | USA, UK, India, Mexico |
GMP Compliance | ISO, cGMP, USFDA/EUGMP, WHO-GMP |
DMF/CEP | Type II |
COFEPRIS | Registered in Mexico |
Free Sale Certificate | Available per batch upon request |
Logistics & Export | |
MOQ | 20 packs/boxes of 100 Caps |
Shelf Life | 24 Months |
Storage | Room temperature (15–30 °C) or cool and dry place |
Incoterms | EXW/FOB/CIF negotiable |
Lead Time | 7 to 10 Days |
Documentation | |
Certificate of Analysis (COA) | Available from manufacturer/distributor |
SDS | Handling guidelines for cytotoxic alkylating agents available from suppliers |
CTD Summary | Not publicly available; may be provided by originator under NDA or with commercial engagement |
Description
Indications & Usage: Lomustine is used orally to treat recurrent high-grade gliomas, Hodgkin’s lymphoma, melanoma, lung cancer, and other malignancies.